Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To investigate liver cancer-associated genes and to explore the molecular basis of liver cancer genesis, we have cloned a novel
hepatocellular carcinoma
(
HCC
)-related gene with a transcript of 2520 base pairs in length named
HCCA2
by mRNA differential display polymerase chain reaction (DDPCR) and screening a placenta cDNA library. No significant homologous protein with known genes was found. Western blot analysis showed that
HCCA2
could be expressed in transfected 293 cells. Northern hybridization analysis showed that
HCCA2
mRNA was expressed in 79% (34/43) patients with
HCC
, most of whom had significantly high expression in
HCC
tissues, while not expressed in corresponding noncancerous liver tissues. The clinical pathological data showed that the
HCCA2
was significantly associated with the invasion of tumour capsule (P = 0.0007) and the expression of ki-67 protein (P = 0.0022). Immunohistochemical staining confirmed that the HCCA2 protein was localized in cytoplasm of liver cancer tissues. According to amino acid analysis of the protein and its localization, it may play a role in a cascade of intracellular signal transduction because the protein was characterized with two Src homology 3 (SH3) binding-domains and several functional motifs of phosphorylation.
...
PMID:Identification and characterization of a novel human hepatocellular carcinoma-associated gene. 1171 Aug 30
HCCA2
(
hepatocellular carcinoma
-associated gene 2) was initially identified as a
HCC
(
hepatocellular carcinoma
)-specific protein and subsequently, a long splice variant of
HCCA2
was identified as a co-activator of transcription factor YY1 (Yin Yang 1). To investigate the role of
HCCA2
in
HCC
genesis and progression, we screened a human fetal liver cDNA library and identified a novel
HCCA2
-interacting protein, MAD2L2 (MAD2 mitotic arrest deficient-like 2 (yeast)). The interaction between
HCCA2
and MAD2L2 was confirmed by in vitro and in vivo binding assays and the interaction domain was mapped to the N-terminus of
HCCA2
by sequential deletion.
HCCA2
and MAD2L2 also colocalized in the nucleus of Hela cells. Furthermore, overexpression of
HCCA2
led to cell cycle arrest at G0/G1 phase and therefore inhibited cell proliferation. Our research suggests that
HCCA2
may play a novel role in cell cycle regulation.
...
PMID:Hepatocellular carcinoma-associated gene 2 interacts with MAD2L2. 1754 14